Reviews on Recent Clinical Trials


Ludovico Abenavoli
University Magna Graecia


Become EABM
Become Reviewer

Editorial promotion: free to download

Volume:1   Issue: 3
Pp: 183-183
Jeffrey M. Weinberg
DOI: 10.2174/157488706778250078

Nelarabine- A New Purine Analog in the Treatment of Hematologic Malignancies

Volume:1   Issue: 3
Pp: 185-192
Sophie Curbo and Anna Karlsson
DOI: 10.2174/157488706778250104

A Review of the Treatment of Psoriasis with Infliximab

Volume:1   Issue: 3
Pp: 201-205
Theodora Vamvouris and Suhail Hadi
DOI: 10.2174/157488706778250122

Bcl-2-Targeted Antisense Therapy (Oblimersen Sodium): Towards Clinical Reality

Volume:1   Issue: 3
Pp: 217-235
Joao Nuno Moreira, Adriana Santos and Sergio Simoes
DOI: 10.2174/157488706778250050

The Emerging Role of Aromatase Inhibitors in the Adjuvant Management of Breast Cancer

Volume:1   Issue: 3
Pp: 237-249
Jean Marc Nabholtz and Joseph Gligorov
DOI: 10.2174/157488706778250069

Clinical Trials in Children

Volume:1   Issue: 3
Pp: 251-258
F. J. Morales-Olivas and C. Morales-Carpi
DOI: 10.2174/157488706778250087

Use of Etanercept in the Treatment of Psoriasis and Psoriatic Arthritis

Volume:1   Issue: 3
Pp: 259-263
Brian S. Fuchs and Suhail Hadi
DOI: 10.2174/157488706778250131

Current Status of Clinical Trials for Glioblastoma

Volume:1   Issue: 3
Pp: 265-281
Michael L. Salgaller and Linda M. Liau
DOI: 10.2174/157488706778250140

Specific Active Immunotherapy of Cancer: Potential and Perspectives

Volume:1   Issue: 3
Pp: 283-292
Roopa Srinivasan and Dennis E. Van Epps
DOI: 10.2174/157488706778250113

Current Management of Extracranial Carotid Artery Disease

Volume:1   Issue: 3
Pp: 293-301
Rabih A. Chaer, Brian DeRubertis, Sheela Patel, Stephanie C. Lin, Craig K. Kent and Peter L. Faries
DOI: 10.2174/157488706778250159